ArticleCureus2025
Effects of Enhanced Recovery After Surgery (ERAS) on Perioperative Outcomes in Shoulder Arthroplasty.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Enhanced Recovery After Surgery (ERAS) is a multidisciplinary, evidence-based management pathway to decrease length of stay (LOS) and complication rates. However, there is minimal research on ERAS regarding total shoulder arthroplasties (TSA). This study aimed to analyze the effects of the ERAS protocol on perioperative outcomes in patients who underwent elective, inpatient TSAs. Methods A retrospective analysis was conducted using the Premier Health Database. Patients who underwent an elective anatomic TSA (aTSA) or reverse TSA (rTSA) were categorized into 'Low ERAS', 'Medium ERAS', or 'High ERAS' based on the number of billable ERAS criteria. Mixed model logistic regressions yielded odds ratios (ORs) and 95% confidence intervals (CIs). An area under the receiver operating characteristic curve (AUROC) and a Youden index were calculated to determine the optimal cutoff point for the best predictive model. Results A total of 74,158 patients were identified. Of them, 15,285 (20.6%) patients were 'High ERAS', 21,809 (29.4%) were 'Medium ERAS', and 37,064 (50.0%) were 'Low ERAS.' 'High ERAS' patients had significantly decreased ORs of experiencing any complication (OR=0.78, p<0.001), cardiopulmonary complications (OR=0.75, p<0.001), in-hospital mortality (OR=0.054, p=0.0040), and blood transfusions (OR=0.58, p<0.0001), and a shorter LOS from 2.19 days to 1.84 days (p<0.0001). The AUROC for the number of ERAS criteria received and in-hospital mortality was 0.75 with an optimal cutoff point of four ERAS criteria. Conclusions TSAs are not an exception to the promising benefits of the ERAS protocol. Efforts should be made to create an official ERAS protocol in TSAs and help hospitals allocate resources to make its implementation possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.